Ingevity Corp Files 8-K on Financials
Ticker: NGVT · Form: 8-K · Filed: 2024-10-29T00:00:00.000Z
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: NGVT
TL;DR
INGEVITY CORP (NGVT) FILED AN 8-K ON 10/29/24 REGARDING FINANCIALS - NO SPECIFICS YET.
AI Summary
Ingevity Corporation filed an 8-K on October 29, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an official update on Ingevity's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing for financial reporting and does not contain information that inherently increases risk.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- 2024-10-29 (date) — Filing Date
FAQ
What specific financial results are being reported in this 8-K filing?
The provided excerpt indicates the filing is related to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but does not detail the specific financial results.
When was this 8-K filing submitted to the SEC?
The filing was submitted on October 29, 2024.
What is the principal business address of Ingevity Corporation?
The principal business address is 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934.
What is Ingevity Corporation's state of incorporation?
Ingevity Corporation is incorporated in Delaware.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-10-29 16:20:30
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange
Filing Documents
- ngvt-20241029.htm (8-K) — 28KB
- ex99109302024.htm (EX-99.1) — 461KB
- image1a.jpg (GRAPHIC) — 143KB
- ngvt-20241029_g1.jpg (GRAPHIC) — 143KB
- 0001653477-24-000096.txt ( ) — 1132KB
- ngvt-20241029.xsd (EX-101.SCH) — 2KB
- ngvt-20241029_lab.xml (EX-101.LAB) — 21KB
- ngvt-20241029_pre.xml (EX-101.PRE) — 12KB
- ngvt-20241029_htm.xml (XML) — 3KB
02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 29, 2024 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and nine months ended September 30, 2024 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release dated October 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: October 29, 2024